C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis

Clinical and Experimental Immunology

Volumn 182, Issue 1, 2015, Pages 23-34

  Mosaad, Y M ^a   Hammad, A ^a   Fawzy, Z ^a   El Refaaey, A ^a   Tawhid, Z ^a   Hammad, E M ^a   Youssef, L F ^b   Elattar, E A A ^c   Radwan, D F ^d   Fawzy, I M ^e  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c Mansoura Military Hospital   (Egypt)

^d Talkha Central Hospital (TCH)   (Egypt)

^e MINISTRY OF HEALTH   (Egypt)

Author keywords

Autoantibody; C1q; Egyptian; Juvenile; Nephritis; Polymorphism; Serum

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; AUTOANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; EGYPTIAN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; JUVENILE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; EGYPT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX;

AUTOANTIBODIES; CHILD; COMPLEMENT C1Q; EGYPT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS NEPHRITIS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84941215768     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12666     Document Type: Article

References (53)

1. Mak A, Tay SH. Environmental factors, toxicants and systemic lupus erythematosus. Int J Mol Sci 2014; 15:16043-56.
2. Botto M, Kirschfink M, Macor P, Pickering MC, Wurzner R, Tedesco F. Complement in human diseases: lessons from complement deficiencies. Mol Immunol 2009; 46:2774-2783.
3. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002; 205:395-406.
4. Santer DM, Hall BE, George TC et al. C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J Immunol 2010; 185:4738-49.
5. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 2000; 25:177-81.
6. Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28:313-4.
7. Gilbert M, Punaro M. Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside. Pediatr Rheumatol Online J 2014; 12:16.
8. Martens HA, Zuurman MW, de Lange AH et al. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Ann Rheum Dis 2009; 68:715-20.
9. Namjou B, Gray-McGuire C, Sestak AL et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun 2009; 10:517-24.
10. Racila DM, Sontheimer CJ, Sheffield A et al. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 2003; 12:124-32.
11. Rafiq S, Frayling TM, Vyse TJ et al. Assessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus. Clin Exp Immunol 2010; 161:284-9.
12. Zervou MI, Vazgiourakis VM, Yilmaz N et al. TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey. Hum Immunol 2011; 72:1210-3.
13. Radanova M, Vasilev V, Dimitrov T et al. Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients. Lupus 2015; 24:280-9
14. Cao CW, Li P, Luan HX et al. Association study of C1qA polymorphisms with systemic lupus erythematosus in a Han population. Lupus 2012; 21:502-7.
15. Devaraju P, Reni BN, Gulati R et al. Complement C1q and C2 polymorphisms are not risk factors for SLE in Indian Tamils. Immunobiology 2014; 219:465-8.
16. Chew CH, Chua KH, Lian LH et al. PCR-RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic lupus erythematosus. Hum Biol 2008; 80:83-93.
17. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
18. Cassidy JT, Petty RE. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, ed. Textbook of pediatric rheumatology, 3rd edn. Philadelphia: W.B. Saunders, 1995:260-322.
19. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003; 24:595-602.
20. Crispin JC, Liossis SN, Kis-Toth K et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010; 16:47-57.
21. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56-9.
22. Bowness P, Davies KA, Norsworthy PJ et al. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994; 87:455-64.
23. Walport MJ, Davies KA, Morley BJ, Botto M. Complement deficiency and autoimmunity. Ann NY Acad Sci 1997; 815:267-81.
24. Sontheimer RD, Racila E, Racila DM. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 2005; 125:14-23
25. Donnelly S, Roake W, Brown S et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum 2006; 54:1543-56.
26. Sellar GC, Blake DJ, Reid KB. Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochem J 1991; 274:481-90.
27. Lewis MJ, Botto M. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity 2006; 39:367-78.
28. Petry F, Loos M. Common silent mutations in all types of hereditary complement C1q deficiencies. Immunogenetics 2005; 57:566-71.
29. Roumenina LT, Sene D, Radanova M et al. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J Immunol 2011; 187:4369-73.
30. Schejbel L, Skattum L, Hagelberg S et al. Molecular basis of hereditary C1q deficiency-revisited: identification of several novel disease-causing mutations. Genes Immun 2011; 12:626-34.
31. Trouw LA, Daha N, Kurreeman FA et al. Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis. Clin Exp Immunol 2013; 173:76-83
32. Goulielmos GN, Samonis G, Apergi M et al. C1q but not mannose-binding lectin (Mbl-2) gene polymorphisms are associated with type 2 diabetes in the genetically homogeneous population of the island of Crete in Greece. Hum Immunol 2013; 74:878-81.
33. Korczowska I, Trzybulska D, Ostanek L et al. Polymorphism of C1q complement (rs292001) occurrence in systemic lupus erythematosus patients. Borgis Prog Med Sci 2012; 12:981-5
34. Zakharyan R, Khoyetsyan A, Arakelyan A et al. Association of C1QB gene polymorphism with schizophrenia in Armenian population. BMC Med Genet 2011; 12:126.
35. Siegert CEH, Daha MR, Halma C, Van Der Voort EAM, Breedveld FC. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 1992; 10:19-23.
36. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 1999; 42:187-8.
37. Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A. IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15:215-9.
38. Potlukova E, Kralikova P. Complement C1q and Anti-C1q antibodies in theory and in clinical practice. Scand J Immunol 2008; 67:423-30.
39. Mahler M, van Schaarenburg RA, Trouw LA. Anti-C1q autoantibodies, novel tests, and clinical consequences. Front Immunol 2013; 4:117.
40. Pradhan V, Rajadhyaksha A, Mahant G et al. Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients. Indian J Nephrol 2012; 22:353-7.
41. Hunnangkul S, Nitsch D, Rhodes B et al. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis Rheum 2008; 58:1116-24. 10.1002/art.23400.
42. Wisnieski JJ, Baer AN, Christensen J et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serological findings in 18 patients. Medicine 1995; 74:24-41.
43. Marto N, Bertolaccini ML, Calabuig E, Hughes GRV, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005; 64:444-8.
44. Horák P, Hermanová Z, Zadrazil J et al. C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 2006; 25:532-6.
45. Horvath L, Czirjak L, Fekete B et al. High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001; 19:667-72.
46. Trouw LA, Groeneveld TW, Seelen MA et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 2004; 114:679-88.
47. Chen Z, Wang GS, Wang GH, Li XP. Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis. Clin Rheumatol 2012; 31:1323-9.
48. Tan Y, Song D, Wu LH, Yu F, Zhao MH. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. BMC Nephrol 2013; 14:63.
49. Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005; 9:183-91.
50. Tsirogianni A, Pipi E, Soufleros K. Relevance of anti-C1q autoantibodies to lupus nephritis. Ann N Y Acad Sci 2009; 1173:243-51.
51. Wu FQ, Zhao Q, Cui XD, Zhang W. C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int 2011; 31:501-5.
52. Hochberg MC. Updating the American College of Rheumatology Revised criteria for the classification of systemic lupus erythematosus [Letter]. Arthritis Rheum 1997; 40:17-25.
53. Nayak A, Ferluga J, Tsolaki AG, Kishore U. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett 2010; 131:139-50.